"immune-responses"

The trial will assess Covid-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac.

The clinical trial, named Solidarity, was first announced on March 18 by WHO director-general Tedros Adhanom Ghebreyesus.